Literature DB >> 8516614

Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis.

T J Yeatman1, G L Nicolson.   

Abstract

Tumor cell metastasis is an extremely complex process governed by many different classes of molecules with each class having a separate function. Metastasis is the result of multiple sequential steps and is a highly organized, nonrandom, and organ-selective process. Recent advances in tumor and molecular biology have permitted the identification of a variety of heterogeneous molecules governing invasion (degradative enzymes, motility factors), adhesion (integrins, selectins, cadherins, immunoglobulin-like superfamily, annexins), and growth (paracrine and autocrine growth factors) of tumor cells. This diverse group of biological molecules is collectively responsible for determining whether tumor cells can progress from a single malignant cell to a lethal, multiorgan, metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8516614

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  25 in total

1.  p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene.

Authors:  Sophie Vasseur; Albrecht Hoffmeister; Stephane Garcia; Claude Bagnis; Jean-Charles Dagorn; Juan Lucio Iovanna
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

2.  CXCR4 regulates the early extravasation of metastatic tumor cells in vivo.

Authors:  Peter Gassmann; Jörg Haier; Kerstin Schlüter; Britta Domikowsky; Claudia Wendel; Ulrike Wiesner; Robert Kubitza; Rainer Engers; Stephan W Schneider; Bernhard Homey; Anja Müller
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

3.  Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.

Authors:  R E Seftor; E A Seftor; J E De Larco; D E Kleiner; J Leferson; W G Stetler-Stevenson; T F McNamara; L M Golub; M J Hendrix
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

4.  A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes.

Authors:  Sharon A Vantyghem; Alison L Allan; Carl O Postenka; Waleed Al-Katib; Michael Keeney; Alan B Tuck; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  Identification of a differentially-expressed message associated with colon cancer liver metastasis using an improved method of differential display.

Authors:  T J Yeatman; W Mao
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

6.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.

Authors:  J E Segall; S Tyerech; L Boselli; S Masseling; J Helft; A Chan; J Jones; J Condeelis
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

Review 7.  Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes.

Authors:  Lori M Millner; Mark W Linder; Roland Valdes
Journal:  Ann Clin Lab Sci       Date:  2013       Impact factor: 1.256

8.  Biliary glycoprotein is overexpressed in human colon cancer cells with high metastatic potential.

Authors:  T J Yeatman; W Mao; R C Karl
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

Review 9.  The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Authors:  Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey Drebin; Izumi Nagatomo; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-05-18       Impact factor: 3.362

Review 10.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.